Home » Market News » DirectorsTalk Highlights » Young Brits with food allergies ‘fear’ eating out
Allergy therapeutics plc

Young Brits with food allergies ‘fear’ eating out

A significant number of young people aged between 16 and 24 and suffering from food allergies or intolerances fear eating out in pubs and restaurants, shocking new research has claimed.

 

Allergy Therapeutics (LON:AGY) is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional fourteen countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.